Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,246 GBX | -0.58% | +1.06% | +15.53% |
08:38pm | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.53% | 24TCr | |
+30.92% | 68TCr | |
+30.35% | 59TCr | |
-3.58% | 36TCr | |
+18.12% | 33TCr | |
+4.08% | 28TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.43% | 17TCr | |
-1.47% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Strikes $2.4 Billion Deal to Buy Fusion Pharmaceuticals